Epidemiological evidence from observational studies suggests that dietary polyphenols (PPs) - phytochemicals found in a variety of plant-based foods - can reduce the risk of developing type 2 diabetes mellitus (T2DM). Clinical trials have also indicated that PPs may help manage the two key features of T2DM, hyperglycemia and dyslipidemia. Since the incidence of T2DM is dramatically increasing worldwide, identifying food-based approaches that can reduce the risk of developing it and help manage its main risk factors in early-stage disease has clinical and socioeconomic relevance. After a brief overview of current epidemiological data on the incidence of T2DM in individuals consuming PP-rich diets, we review the evidence from clinical trials investigating PP-enriched foods and/or PP-based nutraceutical compounds, report their main results, and highlight the knowledge gaps that should be bridged to enhance our understanding of the role of PPs in T2DM development and management.

Pleiotropic Effects of Polyphenols on Glucose and Lipid Metabolism: Focus on Clinical Trials / Matacchione, Giulia; Gurău, Felicia; Baldoni, Simone; Prattichizzo, Francesco; Silvestrini, Andrea; Giuliani, Angelica; Pugnaloni, Armanda; Espinosa, Emma; Amenta, Francesco; Bonafè, Massimiliano; Procopio, Antonio Domenico; Rippo, Maria Rita; Olivieri, Fabiola; Sabbatinelli, Jacopo. - In: AGEING RESEARCH REVIEWS. - ISSN 1568-1637. - (2020), p. 101074. [10.1016/j.arr.2020.101074]

Pleiotropic Effects of Polyphenols on Glucose and Lipid Metabolism: Focus on Clinical Trials

Matacchione, Giulia;Gurău, Felicia;Prattichizzo, Francesco;Silvestrini, Andrea;Giuliani, Angelica;Pugnaloni, Armanda;Espinosa, Emma;Procopio, Antonio Domenico;Rippo, Maria Rita;Olivieri, Fabiola
;
Sabbatinelli, Jacopo
2020-01-01

Abstract

Epidemiological evidence from observational studies suggests that dietary polyphenols (PPs) - phytochemicals found in a variety of plant-based foods - can reduce the risk of developing type 2 diabetes mellitus (T2DM). Clinical trials have also indicated that PPs may help manage the two key features of T2DM, hyperglycemia and dyslipidemia. Since the incidence of T2DM is dramatically increasing worldwide, identifying food-based approaches that can reduce the risk of developing it and help manage its main risk factors in early-stage disease has clinical and socioeconomic relevance. After a brief overview of current epidemiological data on the incidence of T2DM in individuals consuming PP-rich diets, we review the evidence from clinical trials investigating PP-enriched foods and/or PP-based nutraceutical compounds, report their main results, and highlight the knowledge gaps that should be bridged to enhance our understanding of the role of PPs in T2DM development and management.
2020
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11566/277160
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 27
social impact